← Open Payments lookup

MERYL SCICHILONE: Open Payments

NPI 1013608645 · PORTLAND, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,317 in 137 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $851 · 2025 $3,317

Food & beverage: $3,217Education: $100
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP31$1,032
Regeneron Healthcare Solutions, Inc.22$468
GENZYME CORPORATION16$429
Novartis Pharmaceuticals Corporation16$257
GlaxoSmithKline, LLC.15$196
Takeda Pharmaceuticals U.S.A., Inc.9$166
ARS Pharmaceuticals Operations, Inc.7$153
CSL Behring5$139
Amgen Inc.4$103
SANOFI-AVENTIS U.S. LLC1$100

Products named: DUPIXENT, TEZSPIRE, BREZTRI, AIRSUPRA, NUCALA, FASENRA, NEFFY, Rhapsido.

Industry payments across ME — which companies pay providers there.